Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.
Free on-demand webinar: Insulin Biosimlilars
As usually we record our free webinars, so that you have the possibility to watch it on-demand. The latest on-demand webinar is titled: "Insulin Biosimilars: More focus than ever on Glucose Clamp Studies". Dr. Tim Heise, Lead Scientist and Chairman of the Board of Directors at Profil presented the insights into this topic. Watch here. You can find all our previous webinars here.
A novel method to determine the pharmacodynamic onset of action of prandial insulins
Scientists from Profil developed a novel method for the determination of pharmacodynamic onset of action. Read our blog post on the design and results of this study.
Profil recently published a study on effects of sequential treatment
Read our publication on effects of sequential treatment with Lixisenatide, Insulin Glargine, or their combination on meal-related glycaemic excursions, Insulin and Glucagon Secretion, and gastric emptying in patients with type 2 diabetes.
If you are interested in our other publications please click here.
Meet us at upcoming conferences
Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise!
We wish you a good week and look forward to the next "Profil World",
Lars Bochmann - Director Marketing & Business Development